Wockhardt Receives Tentative FDA Approval For Levofloxacin
Wockhardt will launch the product immediately upon expiration of the patent on June 20, 2011. Levofloxacin is a widely used antibacterial drug and belongs to the fluoroquinolone group,
The US Food and Drug Administration (FDA) has approved an expanded indication for Eli Lilly and Company’s Jaypirca (pirtobrutinib) as a first-line treatment for adults with previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) who do not have a 17p deletion.
Ofloxacin is a fluoroquinolone-based antibiotic, which addresses several indications including staph infection, strep throat (Streptococcus), pneumonia, influenza, E Coli, and several sexually transmitted bacterial diseases such as Chlamydia